Requires NJT to establish pilot program to supply certain light rail train sets with opioid antidotes; makes appropriation of $100,000.

This bill requires New Jersey Transit (NJT) to launch a two-year pilot program on light rail trains operating in southern New Jersey, supplying each train set with opioid antidotes (like naloxone) and installing secure storage with silent alerts that notify operators when accessed. NJT must stock at least two doses per train, maintain clear bilingual signage with overdose recognition and emergency contact info, and track antidote usage without requiring staff to administer the antidote or undergo specialized training. The program is funded by a $100,000 appropriation from the General Fund, and NJT must report on its effectiveness within six months of the pilot’s end to decide on a potential statewide expansion. The bill directly affects NJT operations, staff, and passengers on southern light rail routes.